GeneDx Holdings Corp. Lease, Cost
GeneDx Holdings Corp. (WGS) reported Lease, Cost of $9.81 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-02-23
- GeneDx Holdings Corp. lease, cost for the quarter ending 2023-06-30 was $3.04M, a 8.15% decline year-over-year.
- GeneDx Holdings Corp. lease, cost for the quarter ending 2023-03-31 was $3.52M, a 12.13% increase year-over-year.
- GeneDx Holdings Corp. lease, cost for the quarter ending 2022-12-31 was $5.99M.
- GeneDx Holdings Corp. lease, cost for the quarter ending 2022-09-30 was $3.52M.
- GeneDx Holdings Corp. lease, cost for fiscal 2025 was $9.81M, a 6.65% increase from fiscal 2024.
- GeneDx Holdings Corp. lease, cost for fiscal 2024 was $9.20M, a 10.01% decline from fiscal 2023.
- GeneDx Holdings Corp. lease, cost for fiscal 2023 was $10.22M, a 35.94% decline from fiscal 2022.
- GeneDx Holdings Corp. lease, cost for fiscal 2022 was $15.96M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $9.81M 10-K · filed 2026-02-23 | |||
| 2024-12-31 | $9.20M 10-K · filed 2026-02-23 | |||
| 2023-12-31 | $10.22M 10-K · filed 2026-02-23 | |||
| 2023-06-30 | $3.04M 10-Q · filed 2023-08-08 | $6.57M 10-Q · filed 2023-08-08 | $12.55M derived: sum of 3 quarters · filed 2024-02-23 | $16.07M derived: sum of 4 quarters · filed 2024-02-23 |
| 2023-03-31 | $3.52M 10-Q · filed 2023-05-09 | $9.51M derived: sum of 2 quarters · filed 2024-02-23 | $13.02M derived: sum of 3 quarters · filed 2024-02-23 | $16.34M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-12-31 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $9.50M derived: sum of 2 quarters · filed 2024-02-23 | $12.82M derived: sum of 3 quarters · filed 2024-02-23 | $15.96M 10-K · filed 2024-02-23 |
| 2022-09-30 | $3.52M 10-Q · filed 2022-11-14 | $6.83M derived: sum of 2 quarters · filed 2023-08-08 | $9.97M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.31M 10-Q · filed 2023-08-08 | $6.45M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $3.14M 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |